person

Antonio Manuel P. F.

Country
Spain
Department
Pneumology

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
196
Sites with multiple studies

Has run more than one trial at 196 of 513 partner sites.

Specializations

Respiratory Diseases

The investigator specializes in treating various respiratory conditions, with particular focus on bronchiectasis and chronic obstructive pulmonary disease (COPD). Their research extends to innovative therapeutic approaches for managing chronic respiratory conditions.

  • Bronchiectasis management
  • COPD exacerbation treatment
  • Long-term respiratory care

Their work encompasses evaluation of novel treatments for bronchiectasis and investigation of therapies targeting COPD exacerbations.

Inflammatory Airway Conditions

The investigator focuses on treating eosinophilic asthma, exploring advanced therapeutic options for patients whose conditions remain uncontrolled with standard treatments. Their expertise includes evaluation of targeted biological therapies.

  • Severe asthma treatment
  • Biological therapy assessment
  • Treatment optimization strategies

Their research involves investigating combination therapies and comparing treatment escalation approaches in asthma management.

Infectious Disease Prevention

The investigator contributes to research in COVID-19 prevention, focusing on novel antibody treatments and prophylactic approaches. Their work includes evaluation of innovative preventive therapies against viral infections.

  • Antibody-based prevention
  • Viral variant response
  • Prophylactic treatment assessment

Their research encompasses investigation of preventive treatments against various SARS-CoV-2 variants.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.